Vasoactive Intracavernous Pharmacotherapy
- 1 February 1988
- journal article
- review article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 15 (1) , 95-101
- https://doi.org/10.1016/s0094-0143(21)00874-0
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Clinical experience with vasoactive intracavernous pharmacotherapy for treatment of impotenceWorld Journal of Urology, 1987
- Pilot experiments on the actions of drugs injected into the human corpus cavernosum penisBritish Journal of Pharmacology, 1986
- Intracavernous Injection of Papaverine as a Diagnostic and Therapeutic Method in Erectile FailureAngiology, 1984
- Cavernosal Alpha-Blockade: A New Technique for Investigating and Treating Erectile ImpotenceThe British Journal of Psychiatry, 1983
- INTRACAVERNOUS INJECTION OF PAPAVERINE FOR ERECTILE FAILUREThe Lancet, 1982
- Vasoactive intestinal polypeptide (VIP) as a possible neurotransmitter involved in penile erectionActa Physiologica Scandinavica, 1981
- Hemodynamic Mechanism of Erection in the Human PenisArchives of Andrology, 1978
- Studies on the neuropharmacology of papaverine —III. The inhibition of ganglionic transmissionNeuropharmacology, 1972
- Papaverine - induced inhibition of phosphodiesterase activity in various mammalian tissuesLife Sciences, 1971
- A PHARMACOLOGIC AND CLINICAL STUDY OF PAPAVERINArchives of internal medicine (1960), 1916